Is Datametrex AI Limited (DTMXF) a Buy, Sell, or Hold?
Datametrex AI Limited
OTC:DTMXF
$0.0268 USD
$0.0 (6.77%)
- Volume
- 1K
- Average Volume
- 3.57K
- Market Capitalization
- $973.58K
- P/E Ratio
- -0.18
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $0.12
- Year Low
- $0.03
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.70
Industry, Sector & symbol
| Stock Exchange | OTC |
| CEO | Paul Haber |
| Industry | Information Technology Services |
| Sector | Technology |
| Current Symbol | DTMXF |
| CUSIP | 23809L207 |
| CIK | None |
| Web | https://www.datametrex.com |
| Phone | +1 888 524 6333 |
| Currency | USD |
| Employees | 21 |
| Country | CA |
Liquidity
| Debt-to-Equity Ratio | 0.30 |
| Payout Ratio | 0.00 |
| Current Ratio | 1.70 |
| Quick Ratio | 1.70 |
| Cash Ratio | 0.56 |
Sales & Book Value
| Annual Sales | $5.19M |
| Price / Sales | 0.28 |
| Cash Flow | -0.04 |
| Price / Cash Flow | -0.51 |
| Price / Book | 0.30 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-0.24 |
| Trailing P/E Ratio | -0.18 |
| PEG Ratio | 0.00 |
| P/E Growth | 0.00 |
| Net Income | $-5.95M |
| Net Margin | -114.75% |
| Pretax Margin | -110.53% |
| Return on Equity | -212.14% |
| Return on Assets | -40.79% |
Financials Score
| AltmanZ Score | -7.30 |
| Piotroski Score | 2.00 |
| Working Capital | 2.28M |
| Total Assets | 14.58M |
| Ebit | -5.23M |
| Market Cap | 1.29M |
| Total Liabilities | 5.54M |
Poll Results
About Datametrex AI Limited (OTC:DTMXF) Stock
Datametrex AI Limited, along with its affiliated companies, specializes in the collection, analysis, and presentation of both structured and unstructured data. This is achieved using their proprietary machine learning and artificial intelligence technologies, with operations spanning Canada and South Korea. The firm conducts its business through two principal divisions: AI and Technology, and Health Security. Within its Health Security arm, Datametrex delivers a range of services including those related to COVID-19, personalized concierge medical care, and remote telemedicine consultations. This segment also distributes COVID-19 diagnostic kits. Furthermore, it manages the Medi-Call health application, a subscription-based platform designed to link patients with medical professionals, offe ... ring technology-driven e-health and m-health services that encompass prescription fulfillment and arranging physical visits at a user's home or workplace. Conversely, the AI and Technology segment provides expertise in big data analytics, artificial intelligence development, and system integration. Its product portfolio includes NexaSecurity, a platform for discovering and tracking social media activity; Nexalogy's automated social media reporting tools (SMARTS); and its Datametrex Electric Vehicle (EV) solutions. Datametrex AI Limited maintains its corporate headquarters in Toronto, Canada.
2026-06-30 08:00:00
TORONTO, ON / ACCESS Newswire / June 30, 2026 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC:DTMXF) is pleased to announce that its wholly owned subsidiary, QuantIP Licensing Corp. (formerly Paymetrex Payment Solutions Inc.), has completed an evaluation of 2 patents from its intellectual property portfolio using 2 artificial intelligence-driven patent analytics platforms. The evaluation focused on U.S. Patent No.
Datametrex Announces Rebranding of Paymetrex to QuantIP Licensing Corp.
2026-06-23 08:00:00
TORONTO, ON / ACCESS Newswire / June 23, 2026 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) is pleased to announce that its wholly owned subsidiary, Paymetrex Payment Solutions Inc., has changed its name to QuantIP Licensing Corp. ("QuantIP"). The name change reflects the subsidiary's evolving strategic focus on intellectual property licensing and monetization opportunities at the intersection of payment technologies, cybersecurity, artificial intelligence, and emerging quantum encryption solutions.
Datametrex Announces Enterprise Software Automation Contracts
2026-06-15 08:30:00
TORONTO, ON / ACCESS Newswire / June 15, 2026 / Datametrex AI Limited (the "Company" or"Datametrex") (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) is pleased to announce that it has secured multiple enterprise software licensing, implementation, operation, maintenance, and automation service contracts during the first half of 2026. For the period from January 1, 2026 to date, the Company has entered into contracts with an aggregate value of approximately CAD $650,000.
2026-06-03 08:00:00
TORONTO, ON / ACCESS Newswire / June 3, 2026 / Datametrex AI Limited (the "Company" or "Datametrex") (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) is pleased to announce that it has secured multiple enterprise infrastructure contracts totaling approximately CAD $1.8 million related to Nutanix-based data centre modernization initiatives. The Company anticipates net profit of approximately 10% from these contracts.
Datametrex AI Announces Completion Of Hilco Global Patent Portfolio Qualification Review
2026-06-01 08:00:00
TORONTO, ON / ACCESS Newswire / June 1, 2026 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC:DTMXF) is pleased to announce that Hilco Global has completed its initial qualifying due diligence review of the patent portfolio owned by the Company's wholly owned subsidiary, Paymetrex Payment Solutions Inc. ("Paymetrex"). The review was conducted pursuant to a contingency based collaboration between Paymetrex and Hilco Global announced on April 8, 2026.
Imagine Health Achieves Teaching Facility Status Through University of Calgary Faculty Partnership
2026-05-22 08:00:00
TORONTO, ON / ACCESS Newswire / May 22, 2026 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC:DTMXF) is pleased to announce that its wholly-owned subsidiary, Imagine Health Medical Clinics Ltd. ("Imagine Health" or "IH"), has officially established its Calgary Capitol Hill clinic site as a teaching facility following the onboarding of Dr. Michael Tam as a walk-in physician.
Frequently Asked Questions
-
What is the current Datametrex AI Limited (DTMXF) stock price?
-
Datametrex AI Limited(OTC:DTMXF) stock price is $0.0268 in the last trading session. During the trading session, DTMXF stock reached the peak price of $0.1194 while $0.0251 was the lowest point it dropped to. The percentage change in DTMXF stock occurred in the recent session was 6.77% while the dollar amount for the price change in DTMXF stock was $0.0.
-
DTMXF's industry and sector of operation?
-
The OTC listed DTMXF is part of Information Technology Services industry that operates in the broader Technology sector.
-
Who are the executives of DTMXF?
-
Cory Taylor | Advisor
Dong H. Shim | Chief Financial Officer
Jinsun Choi | Managing Director of DM Korea
Michael Frank | Chief Strategy Officer
Michael Kron | COO & Director -
How many employees does DTMXF have?
-
Number of DTMXF employees currently stands at 21. DTMXF operates from 2300 Yonge Street, Toronto, ON M4P 1E4, CA.
-
Link for DTMXF official website?
-
Official Website of DTMXF is: https://www.datametrex.com
-
How do I contact DTMXF?
-
DTMXF could be contacted at phone #+1 888 524 6333 and can also be accessed through its website. DTMXF operates from 2300 Yonge Street, Toronto, ON M4P 1E4, CA.
-
How many shares of DTMXF are traded daily?
-
The average number of DTMXF shares traded daily for last 3 months was 3.57K.
-
What is the market cap of DTMXF currently?
-
The market value of DTMXF currently stands at $973.58K with its latest stock price at $0.0268